HUP0200129A3 - Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents
Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary interventionInfo
- Publication number
- HUP0200129A3 HUP0200129A3 HU0200129A HUP0200129A HUP0200129A3 HU P0200129 A3 HUP0200129 A3 HU P0200129A3 HU 0200129 A HU0200129 A HU 0200129A HU P0200129 A HUP0200129 A HU P0200129A HU P0200129 A3 HUP0200129 A3 HU P0200129A3
- Authority
- HU
- Hungary
- Prior art keywords
- dimethoxycinnamoyl
- prevention
- reduction
- events associated
- anthranilic acid
- Prior art date
Links
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 title 2
- 230000007211 cardiovascular event Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11846299P | 1999-02-03 | 1999-02-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200129A2 HUP0200129A2 (hu) | 2002-05-29 |
| HUP0200129A3 true HUP0200129A3 (en) | 2003-06-30 |
Family
ID=22378750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200129A HUP0200129A3 (en) | 1999-02-03 | 2000-02-02 | Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1171116A4 (hu) |
| JP (1) | JP2002536327A (hu) |
| KR (1) | KR20010101934A (hu) |
| CN (1) | CN1345237A (hu) |
| AU (1) | AU2636600A (hu) |
| BR (1) | BR0007921A (hu) |
| CA (1) | CA2361581A1 (hu) |
| CO (1) | CO5150206A1 (hu) |
| HK (1) | HK1045104A1 (hu) |
| HU (1) | HUP0200129A3 (hu) |
| IL (1) | IL144721A0 (hu) |
| MX (1) | MXPA01007835A (hu) |
| NO (1) | NO20013788L (hu) |
| PL (1) | PL351397A1 (hu) |
| TR (1) | TR200102245T2 (hu) |
| WO (1) | WO2000045811A1 (hu) |
| ZA (1) | ZA200106353B (hu) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) * | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
| US5693337A (en) * | 1994-07-13 | 1997-12-02 | Wakamoto Pharmaceutical Co., Ltd. | Stable lipid emulsion |
| KR19990044478A (ko) * | 1995-09-07 | 1999-06-25 | 간자와 무츠와 | 2-아실아미노벤즈아미드 유도체 및 혈관내막세포 과잉증식에 기인하는 질환의 예방 및 치료제 |
| US6019104A (en) * | 1996-12-30 | 2000-02-01 | Kissei Pharmaceutical Co., Ltd. | Method for the treatment or prevention of restenosis associated with coronary intervention |
-
2000
- 2000-02-02 CA CA002361581A patent/CA2361581A1/en not_active Abandoned
- 2000-02-02 HU HU0200129A patent/HUP0200129A3/hu unknown
- 2000-02-02 AU AU26366/00A patent/AU2636600A/en not_active Abandoned
- 2000-02-02 CN CN00803384A patent/CN1345237A/zh active Pending
- 2000-02-02 PL PL00351397A patent/PL351397A1/xx not_active Application Discontinuation
- 2000-02-02 JP JP2000596931A patent/JP2002536327A/ja not_active Withdrawn
- 2000-02-02 BR BR0007921-9A patent/BR0007921A/pt not_active Application Discontinuation
- 2000-02-02 EP EP00904640A patent/EP1171116A4/en not_active Withdrawn
- 2000-02-02 MX MXPA01007835A patent/MXPA01007835A/es unknown
- 2000-02-02 TR TR2001/02245T patent/TR200102245T2/xx unknown
- 2000-02-02 WO PCT/US2000/002622 patent/WO2000045811A1/en not_active Application Discontinuation
- 2000-02-02 KR KR1020017009744A patent/KR20010101934A/ko not_active Application Discontinuation
- 2000-02-02 IL IL14472100A patent/IL144721A0/xx unknown
- 2000-02-03 CO CO00006604A patent/CO5150206A1/es unknown
-
2001
- 2001-08-02 NO NO20013788A patent/NO20013788L/no not_active Application Discontinuation
- 2001-08-02 ZA ZA200106353A patent/ZA200106353B/en unknown
-
2002
- 2002-07-12 HK HK02105201.2A patent/HK1045104A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200106353B (en) | 2002-08-02 |
| CO5150206A1 (es) | 2002-04-29 |
| BR0007921A (pt) | 2002-09-10 |
| CA2361581A1 (en) | 2000-08-10 |
| EP1171116A4 (en) | 2004-11-17 |
| JP2002536327A (ja) | 2002-10-29 |
| AU2636600A (en) | 2000-08-25 |
| MXPA01007835A (es) | 2002-04-24 |
| CN1345237A (zh) | 2002-04-17 |
| EP1171116A1 (en) | 2002-01-16 |
| PL351397A1 (en) | 2003-04-07 |
| NO20013788D0 (no) | 2001-08-02 |
| IL144721A0 (en) | 2002-06-30 |
| HUP0200129A2 (hu) | 2002-05-29 |
| TR200102245T2 (tr) | 2002-05-21 |
| WO2000045811A1 (en) | 2000-08-10 |
| HK1045104A1 (zh) | 2002-11-15 |
| NO20013788L (no) | 2001-09-28 |
| KR20010101934A (ko) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145732A0 (en) | α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0104425A3 (en) | Anthranilic acid amides and the use thereof for the treatment of angiogenesis | |
| SG78412A1 (en) | Oxime derivatives and the use thereof as latent acids | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| EP1216980A4 (en) | CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME | |
| AU2001252272A1 (en) | Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis | |
| HUP0201334A3 (en) | Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same | |
| HUP0200638A2 (en) | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | |
| HUP0204373A3 (en) | Carboxylic acid amides, pharmaceutical compositions containing these compounds and the use and production thereof | |
| IL143841A0 (en) | Amide compounds and pharmaceutical compositions containing the same | |
| WO2000067801A3 (en) | Prodrugs of chemotherapeutic agents with oxaalkanoic acids | |
| HK1053657A1 (en) | Novel heterocyclic compounds and salts thereof andmedicinal use of the same | |
| IL129270A0 (en) | Class "d" amplifier | |
| HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
| HK1046428A1 (en) | The genome of the hiv-1 inter-subtype (c/b') and use thereof | |
| IL159084A0 (en) | Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| HUP0200129A3 (en) | Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| HUP0201729A2 (en) | Inhibitors of the integrin alpha v betha 6 | |
| HUP0200148A3 (en) | Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| IL125660A0 (en) | Pharmaceutical composition comprising 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the aminobenzoic acid for the treatment or prevention of restenosis and its manufacture | |
| HUP0100957A3 (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same, their use and pharmaceutical compositions containing them | |
| GB2347301B (en) | Fret face 1 | |
| IT1320401B1 (it) | Procedimento per la fabbricazione di componenti di un'ossatura ecomponenti di ossatura. | |
| IL148427A0 (en) | Compound f-15078 and pharmaceutical compositions containing the same |